Loading provider…
Loading provider…
Radiation Oncology Physician in Cleveland, OH
NPI: 1386658656Primary Practice Location
CLEVELAND CLINIC
9500 Euclid Ave, Cleveland, OH
Primary Employer
Cleveland Clinic
clevelandclinic.org
HQ Phone
Get M.D. Samuel's Phone NumberMobile
Get M.D. Samuel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
MI State Medical License
2024 - 2027
OH State Medical License
2001 - 2027
IL State Medical License
2024 - 2026
KY State Medical License
2024 - 2026
WV State Medical License
2024 - 2026
IN State Medical License
2024 - 2025

American Board of Radiology
Radiation Oncology
Cleveland Medical College, Homeopathic
case.edu
Medical School
Until 2001
Cleveland Clinic Foundation
Residency • Radiation Oncology
2001 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77334Design and construction of complex radiation treatment device | 112 | 604 |
| 2 | 77263Complex radiation therapy planning | 102 | 121 |
| 3 | 77300Calculation of radiation therapy dose | 89 | 765 |
| 4 | 772953d radiation therapy planning | 60 | 75 |
| 5 | 77432Stereotactic radiation treatment management of brain lesions, complete course of treatment consisting of 1 session | 51 | 65 |
Authors: Nathan Pennell, Gene Barnett, John Suh, Vineeth Tatineni, Pradnya Patil, Manmeet Ahluwalia, Rupesh Kotecha
Journal: Sci Rep
Publication Date: 2022-01-17
The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
Authors: Zachary Mayo, John Suh
Journal: Neuro Oncol
Relationship between HER2 status and prognosis in women with brain metastases from breast cancer.
Authors: Michael Vogelbaum, Gene Barnett, Robert Weil, Nicholas Marko
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2011-10-22
Lead Sponsor: Case Comprehensive Cancer Center
Intervention / Treatment: DRUG: 18F-fluciclovine, DEVICE: PET/CT of the brain
Lead Sponsor: Case Comprehensive Cancer Center
Intervention / Treatment: PROCEDURE: quality-of-life assessment, RADIATION: stereotactic radiosurgery, PROCEDURE: cognitive assessment
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology, Radiation Therapy Oncology Group
Intervention / Treatment: OTHER: Placebo, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Bevacizumab, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: 3-Dimensional Conformal Radiation Therapy